Androgen Deprivation Therapy in Prostate Cancer - Current Status in M1 Patients

Publisher： Karger

E-ISSN： 2296-5262|38|12|646-652

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.12, 2015-0, pp. : 646-652

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolic changes in patients with prostate cancer during androgen deprivation therapy

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 45-53

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate‐risk, high‐risk, localized, and locally advanced prostate cancer

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1620-1629

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of the Lipid Profile and Atherogenic Risk during Androgen Deprivation Therapy in Prostate Cancer Patients

By  

Urologia Internationalis, Vol. 90, Iss. 1, 2012-12 ,pp. : 41-44

Karger

Access to resources Recommend Favorite

Prospective Study of Estramustine Phosphate for Hormone Refractory Prostate Cancer Patients following Androgen Deprivation Therapy

By  

Urologia Internationalis, Vol. 75, Iss. 1, 2005-07 ,pp. : 43-49

Karger

Access to resources Recommend Favorite

Cognitive function in Chinese prostate cancer patients on androgen‐deprivation therapy: A cross‐sectional study

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 4, 2015-12 ,pp. : 277-281

John Wiley & Sons Inc

Access to resources Recommend Favorite